Enhancing a novel treatment for RA patients.
Pharmaceutical giant, Pfizer, was launching a campaign to convince Rheumatologists that this treatment should be their go-to RA treatment because it redefines their patients’ experience.
Client
Pfizer (Eyeka)
Medium
Print Advert
Description
ARTRIBIX is an effective, fast-acting formulation for the treatment of rheumatoid arthritis (RA), representing the next generation of advanced therapy. It is the first oral (pill) to rapidly relieve important symptoms of RA, providing a safer, less-hassled and more efficient method of elevating the patient experience and improving care. With ARTRIBIX, it’s all about conveying ‘progress without the pain’; showing that ARTRIBIX provides a simpler, more pleasant and precise alternative to the old-fashioned, agonizing methods of methotrexate and injectable biologic treatments. The ‘single serving’ of a pristine white ARTRIBIX pill is illustrated next to a painful serving-full of pills, injections and tonics in an effective minimalistic visual. The new identity was rolled out across the entire business including internal office communications, sales and marketing material, website, social media, office signage and more.
Pfizer | Print Campaign
Published:

Pfizer | Print Campaign

Published: